Premium
Ruxolitinib as first‐line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience
Author(s) -
Zandvakili Inuk,
Conboy Caitlin B.,
Ayed Ayed O.,
CathcartRake Elizabeth J.,
Tefferi Ayalew
Publication year - 2018
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25063
Subject(s) - hemophagocytic lymphohistiocytosis , ruxolitinib , medicine , second line , first line , pediatrics , bone marrow , myelofibrosis , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom